Scarica l'app Stockscreener
2.00
9.09%
-0.20
Dopo l'orario di chiusura:
2.03
0.03
+1.50%
Grace Therapeutics Inc Borsa (GRCE) Ultime notizie
Acasti Pharma stock plunges to 52-week low at $2.02 By Investing.com - Investing.com UK
Aneurysmal Subarachnoid Hemorrhage Market to Reach New Heights - openPR.com
Aneurysmal Subarachnoid Hemorrhage Market to Reach New Heights in Growth by 2034, DelveInsight Predicts | Acasti Pharma Inc., BIT Pharma, Aaron Cook, Haaglanden Medical Centre - Barchart.com
February’s phase III wins include Qyuns’ ankylosing spondylitis data - BioWorld MedTech
Grace Therapeutics secures up to $30 million financing - MSN
ASUS Introduces Ascent GX10 AI Supercomputer Powered by NVIDIA GB10 Grace Blackwell Superchip - Yahoo Finance
Cadence Accelerates AI-Driven Engineering Design and Science with NVIDIA Grace Blackwell - Yahoo Finance
Subarachnoid Hemorrhage Treatment Market Size in the 7MM - openPR
Acasti Pharma stock hits 52-week low at $2.12 amid challenges - Investing.com Australia
Acasti Pharma stock hits 52-week low at $2.12 amid challenges By Investing.com - Investing.com South Africa
Tesla’s fall from grace may have no equal, says JPMorgan: ‘We struggle to think of anything analogous’ - Yahoo Finance
The Inner Circle acknowledges, Grace Merrell Slezak as a Pinnacle Professional Member Inner Circle of Excellence - Yahoo Finance
Regeneron Science Talent Search 2025 Awards More Than $1.8 Million to High School Seniors for Innovative Research on Classifying Celestial Objects, Treating a Rare Muscle Disease and Solving a Long-Standing Math Problem - Yahoo Finance
Matinas BioPharma Appoints Seasoned Biotech Leaders to Board of Directors - The Manila Times
Grace Therapeutics Reports Q3 Progress and Financial Results - TipRanks
Grace Therapeutics Files Form S-3 for Flexible Securities Offering - TipRanks
Grace Therapeutics to offer up to 8.8 mln shares by selling stockholders, SEC Filing shows - Marketscreener.com
Moderna, Inc. - Britannica
CORTCorcept Therapeutics Inc Latest Stock News & Market Updates - StockTitan
New Biotech Stocks at Investorideas.com - Investorideas.com newswire
CORCEPT THERAPEUTICS INC SEC 10-K Report - TradingView
Grace Therapeutics to Participate in the TD Cowen 45th Annual Health Care Conference - The Manila Times
Can Grace Therapeutics' Novel aSAH Treatment Impress Investors at Major Healthcare Conference? - StockTitan
Grace Therapeutics reports positive Phase 3 trial results for GTx-104 - MSN
GRCE: STRIVE-ON Results Reported - MSN
Corcept Therapeutics stock soars to all-time high of $62.34 - MSN
Grace Therapeutics’ (GRCE) “Buy” Rating Reaffirmed at HC Wainwright - Defense World
H.C. Wainwright reiterates buy on Grace Therapeutics stock By Investing.com - Investing.com Australia
H.C. Wainwright reiterates buy on Grace Therapeutics stock - Investing.com India
Promising Potential of Grace Therapeutics’ GTX-104 Drives Buy Rating - TipRanks
Grace Therapeutics On Track For NDA Submission Of GTx-104 For Aneurysmal Subarachnoid Hemorrhage - Nasdaq
GRACE THERAPEUTICS Earnings Results: $GRCE Reports Quarterly Earnings - Nasdaq
Grace Therapeutics Announces Third Fiscal Quarter 2025 Financial Results, Provides Business Update - The Manila Times
Grace Therapeutics Reports Positive Phase 3 STRIVE-ON Trial Results for GTx-104 and Secures $30 Million in Financing; NDA Submission Expected by Mid-2025 - Nasdaq
Grace Therapeutics Inc. (GRCE) reports earnings - Quartz
Grace Therapeutics Announces Third Fiscal Quarter 2025 Financial Results - TradingView
Grace Reports Clinical Trial Victory and Major Cash Infusion in Latest Earnings - StockTitan
Grace Therapeutics, Inc. SEC 10-Q Report - TradingView
Grace Therapeutics secures up to $30 million financing By Investing.com - Investing.com Nigeria
Grace Therapeutics secures $15m for GTx-104 pre-commercial development - MSN
Grace therapeutics announces private placement financing of $30 million - MSN
10.70%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):